Harvard Apparatus (HART) Reports Q3 Loss of $0.19/Share

Go back to Harvard Apparatus (HART) Reports Q3 Loss of $0.19/Share

Harvard Apparatus (HART) Rips Higher on Strong Gen2 Bioengineered Implant Platform Data

November 12, 2015 9:43 AM EST

Harvard Apparatus Regenerative Technology (Nasdaq: HART) shares are ripping higher in early trading Thursday.

Ahead of the opening bell, HART... More